Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


26.07.2021

1 Allergy
1 Ann Allergy Asthma Immunol
3 Arerugi
2 Clin Exp Allergy
4 J Asthma
1 J Pediatr
2 Pediatr Pulmonol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. HAGEMANN J, Onorato GL, Jutel M, Akdis CA, et al
    Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold- An ARIA-EAACI-GA(2) LENconsensus.
    Allergy. 2021 Mar 17. doi: 10.1111/all.14815.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  2. TREVOR J, Lugogo N, Carr W, Moore WC, et al
    Exacerbations in US Severe Asthma: Incidence, Characteristics, Predictors, and Effects of Biologic Treatments.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00501.
    PubMed         Abstract available


    Arerugi

  3. IZUMI K, Tanaka Y, Tanaka K, Inoue Y, et al
    [A LONG PROSPECTIVE OBSERVATIONAL STUDY ON PREVALENCE OF ATOPIC DERMATITIS IN EARLY CHILDHOOD TO ADOLESCENCE].
    Arerugi. 2021;70:384-391.
    PubMed         Abstract available

  4. TEZUKA J
    [INTRODUCTION AND SELECTION OF BIOLOGICS FOR PEDIATRIC ASTHMA].
    Arerugi. 2021;70:359-365.
    PubMed        

  5. NAGASAKI T, Matsumoto H
    [THE INTRODUCTION AND CHOICE OF BIOLOGICS IN ADULT ASTHMA].
    Arerugi. 2021;70:349-358.
    PubMed        


    Clin Exp Allergy

  6. RUPANI H, Murphy A, Bluer K, Renwick C, et al
    Biologics in Severe Asthma- Which one, When and Where?
    Clin Exp Allergy. 2021 Jul 21. doi: 10.1111/cea.13989.
    PubMed         Abstract available

  7. DE BOER GM, Braunstahl GJ, van der Ploeg EK, van Zelst CM, et al
    Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: a double-blind placebo-controlled trial.
    Clin Exp Allergy. 2021 Jul 21. doi: 10.1111/cea.13990.
    PubMed         Abstract available


    J Asthma

  8. RUDIN RS, Qureshi N, Foer D, Dalal AK, et al
    Towards an Asthma Patient-Reported Outcome Measure for use in Digital Remote Monitoring.
    J Asthma. 2021 Jul 19:1-9. doi: 10.1080/02770903.2021.1955378.
    PubMed         Abstract available

  9. REEB-WHITAKER C, LaSee CR, Bonauto DK
    Surveillance of work-related asthma including the emergence of a cannabis-associated case series in Washington State.
    J Asthma. 2021 Jul 21:1-17. doi: 10.1080/02770903.2021.1955379.
    PubMed         Abstract available

  10. CHERNEY K, Bulloch B, Mecham C, Drewek R, et al
    Inhaled corticosteroid prescriptions in the ED for recurrent asthma using IT clinical decision support: Revisit after cessation of an incentive program.
    J Asthma. 2021 Jul 22:1-9. doi: 10.1080/02770903.2021.1959927.
    PubMed         Abstract available

  11. DEENSTRA DD, van Helvoort HAC, Djamin RS, van Zelst C, et al
    Prevalence of hyperventilation in patients with asthma.
    J Asthma. 2021 Jul 22:1-11. doi: 10.1080/02770903.2021.1959926.
    PubMed         Abstract available


    J Pediatr

  12. PARIKH K, Hall M, Kaiser SV, Hogan AH, et al
    Development of a Health Disparities Index: Proof of Concept with Chest Radiography in Asthma.
    J Pediatr. 2021 Jul 17. pii: S0022-3476(21)00689.
    PubMed         Abstract available


    Pediatr Pulmonol

  13. HURST JH, Zhao C, Fitzpatrick NS, Goldstein BA, et al
    Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic.
    Pediatr Pulmonol. 2021 Jul 21. doi: 10.1002/ppul.25578.
    PubMed         Abstract available

  14. NTZOUNAS A, Giannakopoulos I, Lampropoulos P, Vervenioti A, et al
    Changing trends in the prevalence of childhood asthma over 40 years in Greece.
    Pediatr Pulmonol. 2021 Jul 20. doi: 10.1002/ppul.25575.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: